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Activation of group I metabotropic glutamate recep-
tors leads to long-term depression (mGluR-LTD).
Alterations in this form of plasticity have been linked
to drug addiction and cognitive disorders. A key
characteristic of mGluR-LTD is its dependence on
rapid protein synthesis; however, the identities of
the proteins mediating LTD remain elusive. Here,
we identify the X-linked mental retardation protein
OPHN1 as a molecule essential for mGluR-LTD in
the hippocampus. mGluR-LTD induction elicits rapid
dendritic OPHN1 synthesis, which is dependent on
mGluR1 activation and independent of fragile X
mental retardation protein (FMRP). This response is
essential for mGluR-LTD, as acute blockade of
OPHN1 synthesis impedes LTD. mGluR-induced
OPHN1 mediates LTD and associated persistent
decreases in surface AMPARs via interactions with
endophilin A2/3. Importantly, this role of OPHN1 is
separable from its effects on basal synaptic strength,
which require OPHN1’s Rho-GAP activity and inter-
action with Homer1b/c. Thus, our data establish
a role for rapid OPHN1 synthesis in mGluR-LTD.
INTRODUCTION
Activity-dependent changes in the strength of excitatory
synapses are thought to be key cellular mechanisms that con-
tribute to the plasticity of neuronal networks underlying learning
and memory. Two well-defined cellular models in mammals that
measure changes in synaptic strength are long-term potentiation
(LTP) and long-term depression (LTD) (Citri and Malenka, 2008;
Collingridge et al., 2010; Shepherd and Huganir, 2007). Like
memories, they typically occur in two distinct phases: an early
phase that usually depends on modification of preexisting
proteins, and a late phase that is more persistent and dependent
on the synthesis of new proteins (Citri and Malenka, 2008;
Costa-Mattioli et al., 2009; Richter and Klann, 2009; Sutton and300 Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc.Schuman, 2006). While the importance of de novo protein
synthesis in the long-term nature of both memory and its under-
lying forms of synaptic plasticity has been known for a while,
a major difficulty has been the identification of the locally trans-
lated proteins directly linked to changes in synaptic strength.
At hippocampal CA1 synapses, several forms of plasticity that
are dependent on protein synthesis have been described,
including late-phase NMDA receptor (NMDAR)-dependent LTP
and LTD (Citri andMalenka, 2008; Collingridge et al., 2010; Klann
and Dever, 2004), and a form of LTD (mGluR-LTD) that relies on
the activation of group I metabotropic glutamate receptors,
which consist of mGluR1 and mGluR5 (Huber et al., 2000; Oliet
et al., 1997). Activation of either mGluR1 or mGluR5 can induce
LTD in the hippocampal CA1 area (Hou and Klann, 2004; Volk
et al., 2006). Whereas both mGluR-LTD and NMDAR-LTD are
mediated by endocytosis and decreased surface expression of
postsynaptic AMPARs, the two forms of LTD rely on distinct
signaling pathways and do not occlude each other (Carroll
et al., 1999; Moult et al., 2006; Oliet et al., 1997; Snyder et al.,
2001; Waung et al., 2008). Significantly, in contrast to NMDAR-
LTD, where the requirement for protein synthesis is delayed,
mGluR-LTD and the associated decreases in surface AMPARs
require rapid (within 5–10 min) dendritic protein synthesis (Huber
et al., 2000; Snyder et al., 2001). The prevailing model is that
group I mGluRs trigger rapid synthesis of new proteins in
dendrites (referred to as ‘‘LTD proteins’’) that function to cause
LTD by increasing the rate of AMPAR endocytosis at locally
active synapses (Lu¨scher and Huber, 2010; Waung and Huber,
2009). A largely remaining challenge, however, is to determine
the identity of the LTD proteins. Recent studies have unveiled
a few candidate proteins, which in the hippocampus include
tyrosine phosphatase STEP (Zhang et al., 2008), microtubule-
associated protein MAP1B (Davidkova and Carroll, 2007), and
as the leading candidate, activity-regulated cytoskeleton-asso-
ciated protein Arc/Arg3.1 (Park et al., 2008; Waung et al.,
2008). All three proteins are rapidly synthesized in response to
mGluR activation and have been linked to AMPAR endocytosis,
which in the case of Arc involves interactions with endophilin
A2/3 and dynamin (Chowdhury et al., 2006). So far, however,
it has only been shown for Arc that acute blockade of its
de novo synthesis impedes mGluR-LTD and the associated
long-term decreases in surface AMPARs (Waung et al., 2008).
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synthesis appear to be multifaceted, involving the regulation of
general translation initiation factors (Costa-Mattioli et al., 2009;
Richter and Klann, 2009; Waung and Huber, 2009), the elonga-
tion factor EF2 (Davidkova and Carroll, 2007; Park et al., 2008),
as well as RNA binding proteins, such as the fragile X mental
retardation protein (FMRP), the gene product of FMR1 (Bassell
and Warren, 2008; Waung and Huber, 2009). FMRP is thought
to function as a repressor of mRNA translation that binds to
and regulates the translational efficiency of specific dendritic
mRNAs, which include, for instance, Map1b and Arc mRNAs,
in response tomGluR activation, and especially mGluR5 (Bassell
and Warren, 2008; Costa-Mattioli et al., 2009; Darnell et al.,
2011; Do¨len et al., 2007; Napoli et al., 2008). In the absence of
FMRP, this control is lost, leading to excessive and dysregulated
translation of FMRP target mRNAs and enhanced mGluR-LTD
that is protein synthesis independent (Bassell and Warren,
2008; Do¨len et al., 2007; Hou et al., 2006; Huber et al., 2002;
Nosyreva and Huber, 2006). Physical interactions between
mGluR5 and molecules signaling to the translation machinery
have been described, with the Homer scaffolding proteins form-
ing important links to multiple translation control pathways,
including initiation and elongation (Giuffrida et al., 2005; Park
et al., 2008; Ronesi and Huber, 2008). mGluR5 has also been
linked to the regulation of FMRP through direct binding to and
rapid activation (within 1 min) of phosphatase PP2A, which
causes dephosphorylation of FMRP and rapid translational upre-
gulation of FMRP target mRNAs (Narayanan et al., 2007). With
regards to mGluR1-mediated signaling at the CA1 synapse,
less is known. The mGluR1a isoform, which contains the Homer
binding motif, is reportedly absent in hippocampal pyramidal
neurons (Ferraguti and Shigemoto, 2006). Also, the identity of
the proteins specifically synthesized upon mGluR1 activation
remains elusive.
Here, we examined the requirement of the X-linked mental
retardation protein oligophrenin-1 (OPHN1) (Billuart et al.,
1998) for mGluR-LTD. OPHN1 is a Rho GTPase-activating
protein (Rho-GAP), a negative regulator of Rho GTPases, which,
interestingly, besides RhoA, also interacts with Homer 1b/c
(Govek et al., 2004) and endophilin A2/3 family members (see
Figure 3), proteins implicated in mGluR-LTD (Chowdhury et al.,
2006; Park et al., 2008; Ronesi and Huber, 2008; Waung and
Huber, 2009). TheOPHN1 protein is highly expressed in the brain
throughout development, where it is found in neurons of all major
regions, including hippocampus and cortex, and is present in
axons, dendrites and spines (Govek et al., 2004). Significantly,
loss of OPHN1 function has been causally linked to a syndromic
form of mental retardation (MR). Several studies reported the
presence of OPHN1 loss-of-function mutations in families with
MR associated with cerebellar hypoplasia and lateral ventricle
enlargement (Bergmann et al., 2003; des Portes et al., 2004;
Philip et al., 2003; Zanni et al., 2005). Moreover, inactivation of
ophn1 in mice recapitulates some of the human phenotypes,
such as behavioral and cognitive impairments (Khelfaoui
et al., 2007). At the hippocampal CA3-CA1 synapse, during
early development, postsynaptic OPHN1, through its Rho-GAP
activity, plays a key role in activity-dependent maturation and
plasticity of excitatory synapses (Nadif Kasri et al., 2009), sug-gesting the involvement of OPHN1 in normal activity-driven
glutamatergic synapse development. Findings presented here
demonstrate that OPHN1 also plays a critical role in mediating
mGluR-LTD in CA1 hippocampal neurons. We find that OPHN1
expression is translationally induced in dendrites of CA1 neurons
within 10 min of mGluR activation, and that this response is
essential for mGluR-dependent LTD. Acute blockade of new
OPHN1 synthesis impedes mGluR-LTD and the associated
long-term decreases in surface AMPARs. Interestingly, the rapid
induction of OPHN1 expression is primarily dependent on
mGluR1 activation, and is independent of FMRP. Importantly,
OPHN1’s role in mediating mGluR-LTD can be dissociated
from its role in basal synaptic transmission (Nadif Kasri et al.,
2009). Regulation of basal synaptic strength requires OPHN1’s
Rho-GAP activity and association with Homer 1b/c proteins,
whereas mGluR-LTD and the associated long-term decreases
in surface AMPARs are dependent on OPHN1’s interaction
with endophilin A2/3. Thus, our data unveil a critical role for
rapid OPHN1 synthesis in mGluR-LTD, providing not only further
insight into the mechanism and function of mGluR-LTD, but also
into the cellular basis by which mutations in OPHN1 could
contribute to the behavioral and cognitive deficits in OPHN1
patients.
RESULTS
Group I mGluR Activation Induces Rapid Dendritic
Synthesis of OPHN1
Our findings that OPHN1 interacts with Homer 1b/c and endo-
philin A2/3 (see below), proteins with reported roles in mGluR-
dependent LTD, prompted us to explore the involvement of
OPHN1 in this form of plasticity. We reasoned that if OPHN1
plays a direct role in mGluR-LTD, its protein levels should be
rapidly regulated in response to mGluR activation. Therefore,
OPHN1 protein expression was examined by immunocytochem-
istry in CA1 neurons of acute hippocampal slices treated with
DHPG, a selective mGluR1/5 agonist, or control vehicle. We
observed that DHPG treatment of acute slices leads to a rapid
increase in OPHN1 protein levels (within 10 min) in both the
soma and dendrites of CA1 neurons (Figure 1A). Importantly,
this increase was blocked by the protein synthesis inhibitors
anisomycin and cycloheximide (Figure 1A, and data not shown),
but not the DNA transcription inhibitor actinomycin D (see Fig-
ure S1A available online), implying that mGluRs trigger new
synthesis of OPHN1 protein from pre-existing mRNA. Similar
results were obtained by western blot analysis; namely, DHPG
treatment of acute hippocampal slices (for 10 min) caused
a significant increase in OPHN1 protein levels, and this increase
was blocked by anisomycin, but not actinomycin D (Figure 1B
and Figure S1B). Neither of the two inhibitors affected basal
levels of OPHN1 (Figure 1B and Figure S1B). In contrast to
DHPG, treatment of slices with a chemical induction paradigm
for NMDAR-LTD did not trigger an increase in OPHN1 protein
levels (Figure 1C).
The observed increase in dendritic OPHN1 levels within
10 min of DHPG application could be the result of new OPHN1
synthesis from preexisting mRNA residing in the dendrites. We
note that OPHN1 mRNA is present in dendrites of unstimulatedNeuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc. 301
Figure 1. OPHN1 is Rapidly Synthesized in CA1 Dendrites in Response to Group I mGluR Stimulation
(A1) DHPG treatment (100 mM) of acute hippocampal slices increases OPHN1 immunofluorescence (red) in dendrites of CA1 neurons 10 min after DHPG onset.
Pretreatment with anisomycin (20 mM, 30 min) blocks DHPG-induced increases of OPHN1. bIII-tubulin immunoreactivity (green) indicates the presence of
dendrites. Scale bar represents 50 mm. s.p., stratum pyramidale; s.r., stratum radiatum.
(A2) Quantification of OPHN1 immunofluorescence in dendrites. Mean OPHN1 fluorescence intensity was expressed as percentage of control. n = 27–36 slices
(40 mm) from four to five animals per condition, *p < 0.01 (unpaired t test), as compared with control. Error bars represent SEM in all panels.
(B1) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from rats pretreated with anisomycin (20 mM) or control vehicle for 30 min prior to DHPG
(100 mM, 10 min) or ACSF treatment. g-tubulin was used as loading control.
(B2) Mean OPHN1 levels in drug treated slices expressed as percentage of control treated slices. OPHN1 levels were normalized to g-tubulin levels in the same
sample. n = 3–6 slices (400 mm) from three to six animals per condition. *p < 0.01 (unpaired t test), as compared with control.
(C) Western blots of OPHN1 in acute hippocampal slices (CA1 regions) from rats treated with DHPG (100 mM, 10 min), NMDA (20 mM, 3 min), or ACSF. ERK2 was
used as loading control. NMDA treatment does not increase OPHN1 levels; n = 3 slices (400 mm) from three animals; p > 0.05.
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due to rapid transport of OPHN1 from the cell body. To distin-
guish between these two possibilities, we determined whether
DHPG increases OPHN1 protein levels in isolated dendrites.
To this end, slices in which the CA1 pyramidal neuron soma
had been mechanically severed from the dendrites were treated
with DHPG, or control vehicle, for 10 min. DHPG effectively
increased OPHN1 protein levels in the isolated dendrites (Fig-
ure 1D), implying that OPHN1 is locally synthesized in dendrites.
Finally, to determine whether mGluR activation elicits synaptic
synthesis of OPHN1, we prepared hippocampal synaptoneuro-
somes (Figure 1E), and incubated them for 15 min with DHPG
or control vehicle. Western blot analysis revealed an increase
in OPHN1 protein levels in DHPG-treated synaptoneurosomes,
which was blocked by preincubation of the synaptoneurosomes
with anisomycin (Figure 1E). Together, these data provide evi-
dence for mGluR-induced rapid dendritic synthesis of OPHN1
protein in CA1 hippocampal neurons.
DHPG-Induced Rapid Increase in OPHN1 Expression
Depends on mGluR1 Activation and Occurs
in the Absence of FMRP
Group I mGluRs consist of two subtypes, mGluR1 and mGluR5,
and both of these receptors contribute to the induction of
mGluR-LTD in the CA1 hippocampal area (Hou and Klann,
2004; Volk et al., 2006). To determine which of the group I mGluR
subtype(s) is responsible for the rapid DHPG-induced increase in
OPHN1, we applied specific mGluR1 or mGluR5 antagonists
(LY367385andMPEP, respectively) to acute hippocampal slices,
30 min before the addition of DHPG. As expected, OPHN1 levels
wereelevatedwithin10minuponapplicationofDHPGalone. This
elevation, however, was blocked when LY367385 was present
(Figure 1FandFigureS1C). In contrast,MPEPdid not appreciably
affect the DHPG-induced increase in OPHN1 levels (Figure 1F
and Figure S1C). Treatment of slices with either LY367385 or
MPEPalone did not alter basal levels of OPHN1 (data not shown).
These data indicate that the rapid increase of OPHN1 largely
depends on activation of mGluR1, rather than mGluR5.
A key player in the regulation of mGluR-stimulated protein
translation is the FMRP protein. In the absence of FMRP, excess(D1) Representative differential interference contrast (DIC) (left) and OPHN1 imm
dendrites from the pyramidal cell layer. bIII-tubulin immunoreactivity (right) indic
(100 mM, 10 min). Scale bar represents 20 mm.
(D2) Quantification of OPHN1 immunofluorescence in dendrites that were severe
slices (40 mm) from five animals per condition. *p < 0.01 (unpaired t test), as comp
difference in bIII-tubulin levels in cut and uncut dendrites treated with DHPG or c
(E1) Western blots of synaptoneurosome preparation (SN) reveals enrichment of P
(H3) in comparison to whole homogenate (Input) or supernatant (Sup).
(E2) Western blot of synaptoneurosome preparation pretreated with anisomycin
(E3) Mean OPHN1 levels in drug treated synaptoneurosomes expressed as pe
normalized to ERK2 levels in the same sample. n = 3 independent preparations
(F1) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from rats
before DHPG treatment (100 mM, 10 min). ERK2 was used as loading control.
(F2) Mean OPHN1 levels are presented as in (E1). n = 3–6 slices (400 mm) from th
control.
(G1) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from 4- t
(100 mM, 10 min) or ACSF. bIII-tubulin was used as loading control.
(G2) Mean OPHN1 levels are presented as above. n = 4 slices (400 mm) from fou
treated WT slices.basal translation and loss of mGluR-induced translation of
selected mRNAs, including those encoding MAP1B and Arc,
have been reported (reviewed in Bassell and Warren, 2008).
Although loss of FMRP has generally been linked to excessive
mGluR5 signaling (Bassell and Warren, 2008; Do¨len et al., 2007;
Osterweil et al., 2010), at this point, however, a role for FMRP in
the regulation of OPHN1 synthesis could not be excluded. To
assess this, we prepared acute hippocampal slices from Fmr1
knockout (KO)mice and correspondingwild-typemice, and stim-
ulated them with DHPG or control vehicle. OPHN1 expression in
control vehicle-treated slices was not considerably different
between wild-type and Fmr1 KO conditions (Figure 1G). More-
over,DHPGtreatmentofFmr1KOderivedslices resulted ina rapid
increase in OPHN1 protein levels to an extent similar as seen in
wild-type DHPG-treated slices (Figure 1G). Thus, loss of FMRP
does neither affect basal OPHN1 levels nor the mGluR-induced
upregulation of OPHN1, implying that the synthesis of OPHN1 in
hippocampal neurons is not subject to FMRP regulation.
OPHN1 Knockdown Impairs mGluR-LTD
Based on our findings that OPHN1 becomes rapidly upregulated
in dendrites of CA1 neurons in response to mGluR activation,
we next investigated whether OPHN1 is required for mGluR-
mediated LTD at CA1 synapses. To this end, we utilized a lenti-
virus that coexpresses EGFP and a short-hairpin (sh) RNA
(OPHN1#2) to knockdown OPHN1 mRNA and protein (Nadif
Kasri et al., 2009). The OPHN1#2 shRNA significantly reduced
endogenous OPHN1 protein levels in hippocampal neurons,
whereas a control scrambled shRNA (scr#1) was ineffective (Fig-
ure 2A) (Nadif Kasri et al., 2009). We opted for this approach
because it allows for spatio-temporal regulation of endogenous
OPHN1 expression. RNAi-mediated temporal knockdown of
OPHN1 selectively in CA1 neurons has no detectable effect on
presynaptic function and it minimizes the possibility of develop-
mental compensations (Nadif Kasri et al., 2009); both of these
events could affect the induction and expression of mGluR-
LTD (Khelfaoui et al., 2007).
CA1 neurons in cultured hippocampal slices were infected
with the OPHN1#2 shRNA containing lentivirus, and 8 to
10 days post-infection the magnitude of mGluR-dependentunofluorescence (middle) images from CA1 regions where a cut severed the
ates the presence of dendrites. Top: vehicle treated; bottom: DHPG treated
d (cut) from the soma and in neighboring uncut dendrites, akin as in A2. n = 5
ared with control. Quantification of bIII-tubulin immunofluorescence reveals no
ontrol vehicle; p > 0.05.
SD-95 and synaptophysin (Syn) and a reduction in bIII-tubulin and histone H3
(20 mM) or control vehicle 30 min prior to DHPG treatment (100 mM, 15 min).
rcentage of control vehicle treated synaptoneurosomes. OPHN1 levels were
from three animals. *p < 0.01 (unpaired t test), as compared with control.
pretreated with LY367385 (100 mM), MPEP (10 mM), or control vehicle 30 min
ree to six animals per condition. *p < 0.01 (unpaired t test), as compared with
o 6-week-old Fmr1 KO mice and corresponding WT mice treated with DHPG
r animals per condition. *p < 0.01 (unpaired t test), as compared with control
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Figure 2. Knockdown of OPHN1 Impairs DHPG-Induced LTD
(A) Left panel: Dissociated hippocampal cultures were infected with lentiviral vectors expressing scr#1 shRNA and EGFP, OPHN1#2 shRNA and EGFP, or
OPHN1#2 shRNA and OPHN1WT-EGFP. Eight days postinfection, cell extracts were analyzed by western blotting with anti-OPHN1 1296 and anti-g-tubulin
antibody as loading control. Right panel: MeanOPHN1 levels in infected neurons presented as a percentage of scr#1 shRNA expressing cells. OPHN1 levels were
normalized to g-tubulin levels in the same sample. OPHN1#2 shRNAs significantly decreased OPHN1 levels. n = 3 in all cases, *p < 0.001, t test. Error bars
represent SEM.
(B and C) DHPG-induced LTD in hippocampal brain slice cultures. Normalized EPSC amplitudes plotted against time from pairs of uninfected and (B) OPHN1#2
shRNA or (C) OPHN1#2 shRNA + OPHN1WT infected CA1 pyramidal neurons during baseline and after LTD induction (100 mM DHPG, 5 min). Top panels:
representative traces of AMPAR-EPSCs before and after DHPG induction for control (black) and infected (green) neurons. Scale bars represent 30ms and 20 pA.
Bottom left panels: EPSC amplitudes normalized to the baseline of uninfected neurons (unscaled). Bottom right panels: EPSC amplitudes normalized to baseline
responses of each cell (scaled). (B) n = 10 pairs; (C) n = 7 pairs. AMPAR EPSCs measured between 35 and 40 min after DHPG treatment, p < 0.01, paired t test.
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Rapid OPHN1 Synthesis Mediates mGluR-LTDLTD induced in control uninfected and OPHN1#2 shRNA
infected cells with bath application of DHPG (100 mM, 5 min)
was examined. Consistent with previous studies (Huber et al.,
2000, 2001; Volk et al., 2006), DHPG caused a depression of
AMPAR-mediated synaptic transmission in control cells, which
is protein translation dependent, and, notably, is attenuated
by blockade of mGluR1 with LY367385 throughout the experi-
ment (Figure 2B and Figures S3A and S3B). When compared
to mGluR-LTD induced in simultaneously recorded control
cells, knockdown of OPHN1 greatly reduced the magnitude of304 Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc.mGluR-LTD. A depression in AMPAR-mediated synaptic trans-
mission of approximately 40% was observed in control cells
versus 10% in OPHN1#2 shRNA expressing cells, 30–35 min
after DHPG application (Figure 2B). To ensure that this effect
was specifically caused by impaired OPHN1 expression, we per-
formed rescue experiments by using OPHN1 cDNA that is resis-
tant to OPHN1#2 shRNA-mediated RNAi (Nadif Kasri et al.,
2009). The levels of OPHN1 expression in hippocampal neurons
coexpressing RNAi-resistant OPHN1WT and OPHN1#2 shRNA
were restored to normal levels (Figure 2A), and, most
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Figure 3. Disruption of OPHN1 Interactions with
Homer 1b/c and Endo2/3
(A) Domain structure of OPHN1. The Homer 1b/c and
Endo2/3 binding sites and the R409Q amino acid substi-
tution in GAP domain that abolishes OPHN1’s Rho-GAP
activity are indicated.
(B) Homer 1b-GST fusion protein, or GST alone, immobi-
lized on beads was incubated with extracts from HEK293T
cells expressing OPHN1WT-EGFP or OPHN1Hom-EGFP.
Bound OPHN1 was detected by immunoblotting with anti-
GFP antibody. GST-fusion proteins used are indicated by
Coomassie blue (CBB) staining. TL, total lysate.
(C) Homer 1b-GST fusion protein (lower panel, CBB
staining) immobilized on beads was first incubated with
synaptosomal extracts followed by pep-OPHN1Hom or
pep-contHom at indicated concentrations. Bound OPHN1
was detected by immunoblotting with anti-OPHN1 anti-
body.
(D) Endo2-GST fusion protein, or GST alone (lower panel,
CBB staining), immobilized on beads was incubated with
extracts from HEK293T cells expressing OPHN1WT,
OPHN1-PRD1*, -PRD2*, or -PRD3*(= OPHN1Endo)-EGFP
fusion proteins. Bound OPHN1 was detected by immu-
noblotting with anti-GFP antibody.
(E) Extracts prepared from acute hippocampal brain slices
(CA1 regions), pretreated with cycloheximide (CHX,
50 mM), or control vehicle, for 5 min and then treated with
DHPG (100 mM), or ACSF, for 10 min were incubated with
anti-Endo2 antibody, or control IgG. The immunoprecipi-
tates (IP) and total lysates (TL) were analyzed by immu-
noblotting with indicated antibodies. Relative amount of
coimmunoprecipitated OPHN1 with Endo2 (compared to
control vehicle) is shown in right panel. n = 3, *p < 0.01
(unpaired t test), as compared with control vehicle- treated
slices. Error bars represent SEM.
(F) Endo2-GST fusion protein (lower panel, CBB staining) immobilized on beads was first incubated with synaptosomal extracts followed by pep-OPHN1Endo
or pep-contEndo at indicated concentrations. Bound OPHN1 was detected by immunoblotting with anti-OPHN1 antibody.
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Rapid OPHN1 Synthesis Mediates mGluR-LTDimportantly, the magnitude of mGluR-LTD was comparable to
that of control neurons (Figure 2C). Thus, knockdown of
OPHN1 impairs mGluR-LTD.
One possible explanation for the impaired mGluR-LTD
is that it is due to reduction in basal synaptic strength, as
OPHN1 RNAi depresses glutamatergic synaptic transmission
(Figure 2B, left panel before DHPG application, and see Fig-
ure 4A), thereby occluding LTD. Alternatively, however, activity-
dependent OPHN1 induction could play a critical role in medi-
ating mGluR-LTD independent of its effects on basal synaptic
strength. Distinguishing between these two possibilities requires
a dissociation of OPHN1’s role in regulating basal synaptic
transmission and mGluR-LTD. To determine whether such
dissociation can be achieved, we resorted to OPHN1 mutants
and synthetic blocking peptides that selectively disrupt the inter-
action between OPHN1 and OPHN1-binding partners present in
dendritic spines; the synaptic effects of these mutants and
peptides were subsequently tested.
Selective Disruption of OPHN1 Interactions
with Its Postsynaptic Binding Partners Homer 1b/c,
RhoA, and Endophilin A2/3
We previously described an interaction between OPHN1 and the
small GTPase RhoA, as well as Homer 1b/c, at the postsynaptic
site of hippocampal neurons (Govek et al., 2004). We showedthat OPHN1 through its Rho-GAP domain represses the RhoA/
Rho-kinase pathway in spines of CA1 neurons (Govek et al.,
2004), and generated an OPHN1 mutant, OPHN1GAP (R409Q)
that abolishes its Rho-GAP activity (Nadif Kasri et al., 2009;
see Figure 3A). This mutant failed to rescue the OPHN1 RNAi-
evoked defects in structural and functional maturation of gluta-
matergic synapses (Nadif Kasri et al., 2009). With regards to
OPHN1 and Homer 1b/c, we demonstrated that these proteins
physically interact and colocalize in dendritic spines (Govek
et al., 2004; Figure S4A); the importance of this association
remained however unknown. Introduction of mutations in the
consensus Homer binding motif located in the N terminus of
OPHN1 disrupted its interaction with Homer 1b/c (OPHN1Hom;
Figures 3A and 3B) (Govek et al., 2004). As an additional tool
to acutely disrupt this interaction, we designed a peptide con-
sisting of an OPHN1 sequence that contains the Homer ligand
domain (pep-OPHN1Hom; Figure 3C). The peptide was made
cell permeable by addition of the human immunodeficiency
virus-type 1 Tat sequence. We found that this peptide disrupts
the OPHN1-Homer 1b/c interaction (Figure 3C), whereas
a control peptide containing three amino acid substitutions in
the binding motif did not (pep-contHom, Figure 3C). Notably,
pep-OPHN1Hom did not disrupt the association between Homer
1b/c and dynamin-3, nor between Homer 1b/c and mGluR5
(Figures S4B and S4C).Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc. 305
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Rapid OPHN1 Synthesis Mediates mGluR-LTDA third class of proteins we found to associate with OPHN1 are
members of the endophilin A family, which include endophilin A1,
A2, and A3 (Kjaerulff et al., 2011). In previous studies, we and
others demonstrated a direct interaction between OPHN1 and
endophilin A1 (Endo1) (Khelfaoui et al., 2009; Nakano-Kobayashi
et al., 2009), which is predominantly expressed in presynaptic
nerve terminals, and showed that this interaction is critical for
OPHN1’s presynaptic function in synaptic vesicle retrieval
(Nakano-Kobayashi et al., 2009). The endophilin A2 (Endo2)
and endophilin A3 (Endo3) proteins, on the other hand, are
enriched in postsynaptic compartments and have been impli-
cated in the regulation of AMPAR endocytosis in hippocampal
neurons (Chowdhury et al., 2006). Given that all three family
members are highly conserved, containing an N-terminal
N-BAR (Bin/Amphiphysin/Rvs) domain and a C-terminal SH3
domain (Kjaerulff et al., 2011), we tested whether OPHN1 also
interacts with Endo2 and 3. We found that this is indeed the
case (Figures 3D and 3E and Figures S5A and S5B), and
that the interaction is mediated via binding of the third proline
rich domain (PRD3) of OPHN1 to the SH3 domain of Endo2/3
(Figure 3D and Figure S5B, data not shown). Moreover,
coimmunoprecipitation experiments revealed that treatment of
hippocampal slices with DHPG leads to increased binding of
OPHN1 to Endo2/3, which, notably, is protein synthesis depen-
dent (Figure 3E). Mutations in the PRD3 of OPHN1 (PRD3*)
disrupt its association with Endo2/3 (OPHN1Endo; Figure 3D
and Figure S5B). Specific disruption of the OPHN1-Endo2/3
interaction was also achieved by employing a peptide consisting
of an OPHN1 sequence that contains the endophilin ligand
domain (pep-OPHN1Endo), but not a control peptide containing
three amino acid substitutions in the bindingmotif (pep-contEndo)
(Figure 3F and Figures S5C–S5E). Importantly, all three OPHN1
mutants, OPHN1GAP, OPHN1Hom, and OPHN1Endo still resided
in spines, as revealed by two-photon microscopy of CA1
neurons of hippocampal slices (Figure S5F). Also, treatment of
slices with either pep-OPHN1Hom or pep-OPHN1Endo did not
affect the localization of OPHN1 in spines (data not shown).
Regulation of Basal Synaptic Transmission by OPHN1
Requires Its Rho-GAP Activity and Interaction
with Homer 1b/c, but Not Endo2/3
To determine whether disruption of any of the above-described
interactions could dissociate OPHN1’s role in regulating basal
synaptic transmission and mGluR-LTD, we began by examining
the synaptic effects of replacing endogenous OPHN1with one of
the three OPHN1 mutants using a lentivirus-mediated molecular
replacement strategy (Nadif Kasri et al., 2009). To this end, lenti-
viral vectors that coexpress OPHN1#2 shRNA and RNAi-resis-
tant OPHN1GAP, OPHN1Hom, or OPHN1Endo fused to EGFP
were generated. We first tested whether any of these mutants
could rescue the decrease in basal synaptic strength caused
by OPHN1 RNAi in CA1 neurons (Figures 4A and 4F). Coexpres-
sion of OPHN1WT withOPHN1#2 shRNA restored basal synaptic
strength to normal (Figures 4B and 4F). In contrast, coexpression
of OPHN1GAP or OPHN1Hom failed to rescue the OPHN1#2
shRNA-evoked defects in AMPAR- and NMDAR-mediated
transmission (Figures 4C, 4D, and 4F). Interestingly, coexpres-
sion of OPHN1Endo rescued the defects in basal synaptic306 Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc.transmission akin to OPHN1WT (Figures 4E and 4F). Notably, all
OPHN1 mutants were expressed at similar levels (Figure S6).
These results indicate that OPHN1’s Rho-GAP activity and inter-
action with Homer 1b/c, but not Endo2/3, are important for regu-
lating basal synaptic strength.
OPHN1 Mediates mGluR-Dependent LTD through
Interaction with Endo2/3
Next, we examined the abilities of OPHN1GAP, OPHN1Hom, and
OPHN1Endo to rescue the deficit in mGluR-LTD caused by
OPHN1 knockdown, using the above described replacement
strategy. CA1 neurons coexpressing OPHN1#2 shRNA and
OPHN1GAP, or OPHN1Hom, displayed impaired mGluR-LTD to
an extent similar to that seen in cells expressing OPHN1#2
shRNA alone (Figures 5A, 5B, and 5D). Most interestingly,
neurons coexpressing OPHN1#2 shRNA and OPHN1Endo,
although having normal basal synaptic transmission, showed a
defect in mGluR-LTD (Figures 5C and 5D). These results indicate
that the effects of OPHN1 on basal synaptic transmission and
mGluR-LTD are dissociable and involve distinct protein-protein
interactions, with the interaction between OPHN1 and Endo2/3
being critical for its role in mGluR-LTD.
To corroborate and extent these findings, we next investigated
the impact of pep-OPHN1Endo and pep-OPHN1Hom, which
disrupt OPHN1-Endo2/3 and OPHN1-Homer interactions,
respectively, on mGluR-LTD in acute hippocampal brain slices.
Postsynaptic infusion of pep-OPHN1Endo through a whole-cell
patch pipette (30 min prior to DHPG application) significantly
reduced mGluR-LTD compared to the control peptide (Fig-
ure 6A). Infusion of CA1 neurons with pep-OPHN1Endo had no
effect on basal synaptic transmission (Figure 6B). These findings
indicate that the actions of pep-OPHN1Endo are rapid and
corroborate our results obtained with the OPHN1Endo mutant.
When pep-OPHN1Hom was included in the pipette, mGluR-LTD
and baseline EPSC amplitudes were comparable to those of
the control peptide (Figures 6C and 6D). Of note, the lack of an
effect on basal synaptic transmission upon short-term disruption
of the OPHN1/Homer 1b/c interaction with pep-OPHN1Hom is
consistent with previous findings that prolonged, but not short-
term, knockdown of OPHN1 reduces basal synaptic transmis-
sion (Nadif Kasri et al., 2009). Together, our data indicate that
OPHN1 plays a crucial role in mediating mGluR-LTD, and that
OPHN1’s interaction with Endo2/3, but not Homer 1b/c proteins,
is critical for this event.
Previous studies have shown that activation of group I mGluRs
leads to persistent decreases in surface AMPAR expression
levels that mediate LTD (Snyder et al., 2001; Waung et al.,
2008). Since the OPHN1-Endo2/3 interaction is critical for
mGluR-LTD, we directly tested whether it is important for
mGluR-induced changes in surface AMPAR expression and
endocytosis. To quantify AMPAR surface levels and the degree
of AMPAR internalization, we employed a biochemical method
to crosslink surface-only AMPAR subunits. Acute slices of
hippocampal area CA1 were preincubated with no peptide,
pep-contEndo or pep-OPHN1Endo. The CA1 slices were then
treated with DHPG or control vehicle (for 10 min), and 50 min
later incubated with the membrane-impermeant cross-linking
reagent bis (sulfosuccinimidyl) suberate (BS3). Western blotting
Figure 4. Replacement of Endogenous OPHN1 with OPHN1Endo, But Not OPHN1GAP or OPHN1Hom, Rescues Basal AMPAR and NMDAR
EPSCs
(A–E) Amplitudes of AMPAR (left panel) and NMDAR (right panel) EPSCs of uninfected neurons are plotted against simultaneously recorded neighboring neurons
expressing (A) OPHN1#2 shRNA, (B) OPHN1#2 shRNA+OPHN1WT, (C) OPHN1#2 shRNA+OPHN1GAP, (D) OPHN1#2 shRNA+OPHN1Hom, or (E) OPHN1#2
shRNA+OPHN1Endo. Gray symbols represent single pairs of recordings; black symbols show mean ± SEM. Inserts in each panel show sample averaged traces;
green traces, infected neurons; black traces, uninfected neighboring neurons. Scale bars represent 20 ms and 20 pA. See Supplemental Information for
quantifications.
(F) Summary (mean ± SEM) of effects of expressing OPHN1#2 shRNA alone or together with OPHN1WT or one of the indicated OPHN1 mutants on AMPAR (left)
andNMDAR (right) EPSCs calculated as the averaged ratios obtained frompairs of infected and uninfected neighboring neurons. Data are shown asmean ±SEM.
*p < 0.05, paired t test.
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GluR1 expression and an increase in internalized GluR1 levels
1 hr after DHPG treatment in the no peptide and control
peptide preincubated CA1 slices (Figures S7A and S7B). The
DHPG-induced decrease in cell-surface GluR1 expression and
increase in internal GluR1 levels were, however, significantly
attenuated in CA1 slices that were preincubated with pep-
OPHN1Endo (Figures S7A and S7B). Of note, the pep-OPHN1Endo
peptide did not affect basal levels of surface GluR1 (Figures S7A
and S7B). Similar results were obtained for the GluR2 AMPAR
subunit (data not shown). To corroborate these findings,
we undertook an immunofluorescence approach to measure
AMPAR surface levels. Cultured hippocampal neurons, preincu-
bated with no peptide, pep-contEndo or pep-OPHN1Endo, were
treated with DHPG or control vehicle (for 10 min), and 1 hr
after treatment labeled with an N-terminal directed anti-GluR1
antibody. Consistent with our above biochemical data, pep-
OPHN1Endo did not affect basal levels of surface GluR1, butattenuated the decrease of surface GluR1 observed 1 hr post-
DHPG (Figures 6E and 6F). We conclude that the OPHN1-
Endo2/3 interaction plays a key role in mGluR-triggered long-
term decreases in surface AMPARs.
Acute Blockade of mGluR-Induced OPHN1 Synthesis
Impedes mGluR-LTD
Our data showed that mGluR activation triggers rapid synthesis
of OPHN1 and that OPHN1 mediates mGluR-LTD and the asso-
ciated long-term decreases in surface AMPAR expression
through its interaction with Endo2/3. The latter experiments,
however, did not address whether new synthesis of OPHN1 in
response to mGluR activation is required for these events. To
prevent/block mGluR-elicited new synthesis of OPHN1, we em-
ployed a previously described siRNA (Ophn1#2 siRNA) (Govek
et al., 2004). We reasoned that acute delivery ofOphn1#2 siRNA
should only prevent the DHPG-induced rapid increase in OPHN1
expression, without affecting basal levels of OPHN1, given thatNeuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc. 307
Figure 5. Molecular Dissociation of OPHN1’s Role in Regulating Basal Synaptic Strength and mGluR-LTD
(A–C) Normalized EPSC amplitudes plotted against time from pairs of uninfected and (A) OPHN1#2+OPHN1GAP, (B) OPHN1#2+OPHN1Hom, or (C)
OPHN1#2+OPHN1Endo infected neurons during baseline and after LTD induction (100 mM DHPG, 5 min). Top panels: representative traces of AMPAR-EPSCs
before and after DHPG induction for control and infected neurons. Scale bars represent 30ms and 20 pA. Bottom left panels: EPSC amplitudes normalized to the
baseline of uninfected neurons (unscaled). Bottom right panels: EPSC amplitudes normalized to the baseline responses of each cell (scaled).
(D) Baseline (DHPG ) and 30–35 min post-DHPG (DHPG +) data are summarized. Baseline AMPAR currents and AMPAR currents 30–35 min after DHPG
application are normalized to baseline AMPAR currents of adjacent uninfected neurons for each indicated condition. Data are shown as mean ± SEM. *p < 0.005,
paired t test. See Supplemental Information for quantifications.
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synthesis for a period of up to several hours in the absence of
DHPG (Figure S8A, data not shown). To test this, Ophn1#2
siRNA or a nontargetingOphn1mismatch siRNAwas introduced
into cultured hippocampal neurons using lipidmediated transfer.
Thirty minutes after siRNA delivery, neurons were treated with308 Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc.DHPG or control vehicle for 10 min, and analyzed by confocal
microscopy (Figure 7A). Of note, we know from experiments
using fluorescently labeled siRNAs that the siRNAs are effec-
tively taken up by the cells within a 30 min time frame (Figures
S8B–S8D). DHPG stimulation over a period of 10 min induced
a significant increase in dendritic OPHN1 levels in neurons
Figure 6. OPHN1 Interaction with Endo2/3, But Not Homer 1b/c, Is Required for mGluR-LTD and Associated Decreases in Surface AMPARs
(A) Using simultaneous dual-patch-clamp recording from two neurons, DHPG-induced mGluR-LTD (100 mM, 5 min) is present in cells infused with control pep-
contEndo (10 mM), but is blocked in cells infused with pep-OPHN1Endo (10 mM). Neurons were infused with respective peptides 30 min prior to DHPG application.
Scale bars represent 30 ms and 20 pA. n = 6 pairs, p < 0.05, paired t test; see Supplemental Information for quantifications.
(B) Average normalized EPSC amplitudes of CA1 neurons from acute hippocampal slices infused with 10 mM pep-contEndo or pep-OPHN1Endo for 60 min (n = 4
pairs). No changes in EPSC amplitudes were observed, paired t test.
(C) Using simultaneous dual-patch-clamp recording from two neurons, mGluR-LTD (DHPG 100 mM, 5min) is induced in cells infusedwith pep-OPHN1Hom (10 mM)
and pep-contHom (10 mM). Neurons were infused 30 min prior to DHPG application. Scale bars represent 30 ms and 20 pA. n = 5 pairs, p > 0.05, paired t test; see
Supplemental Information for quantifications.
(D) Average normalized EPSC amplitudes of CA1 neurons from acute hippocampal slices infused with 10 mM pep-contHom or pep-OPHN1Hom peptide for 60 min
(n = 4 pairs). No changes in EPSC amplitudes were observed, paired t test.
(E) Representative images of surface GluR1 in cultured hippocampal neurons pretreated with no peptide (no pep), pep-contEndo, or pep-OPHN1Endo (5 mM) 3 hr
prior to DHPGor control media (10min) treatment. 1 hr posttreatment, neurons were live-labeled with anti-GluR1 antibody, fixed and processed for surfaceGluR1
immunofluorescence. Scale bars represent 10 mm in top and 2 mm in bottom panels.
(F) Quantification of the number of surface GluR1 puncta presented as percentage of control (i.e., DHPG-unstimulated and no peptide). n = 74–118 neurons from
five cultures per condition. *p < 0.05 (unpaired t test), as compared with control. Error bars represent SEM.
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Figure 7. Acute Blockade of New OPHN1 Synthesis Blocks mGluR-Induced LTD and Long-Term Decreases in Surface AMPARs
(A) Representative images of OPHN1 immunofluorescence in cultured hippocampal neurons pretreated (30 min in Lipofectamine) with Ophn1#2 siRNA or
mismatch siRNA. Neurons were then treated with DHPG (100 mM) or control media, and fixed 10 min after onset of treatment. Scale bars represent 10 mm in top
and 2 mm in bottom panels.
(B) Quantification of OPHN1 immunofluorescence in dendrites. Mean OPHN1 fluorescence intensity presented as percentage of mismatch siRNA. n = 27–49 cells
from three cultures per condition, *p < 0.05 (unpaired t test), as compared with mismatch siRNA. Error bars represent SEM in all panels.
(C) Representative images of surfaceGluR1 in cultured hippocampal neurons pretreated withOphn1#2 siRNA ormismatch siRNA 30min prior to DHPGor control
media (10 min) treatment. One hour post-DHPG or control media, neurons were live-labeled with anti-GluR1 antibody, fixed and processed for surface GluR1
immunofluorescence. Scale bars represent 10 mm in top and 2 mm in bottom panels.
(D) Quantification of the number of surface GluR1 puncta presented as percentage of mismatch siRNA. n = 30–35 neurons from three cultures per condition,
*p < 0.05 (unpaired t test), as compared with control mismatch siRNA.
(E) Average normalized EPSC amplitudes of CA1 neurons from acute hippocampal slices recorded with pipettes containing 25 nMmismatch siRNA orOphn1#2
siRNA for 60 min (n = 5 pairs). No changes in EPSC amplitudes were observed, paired t test.
(F) DHPG applied to the bath resulted in LTD of EPSC amplitudes in neurons filled with mismatch siRNA, but was blocked in neurons filled with Ophn1#2 siRNA.
n = 6 pairs.
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was abolished in neurons subjected to the Ophn1#2 siRNA
(Figures 7A and 7B, DHPG). Notably, incubation of neurons
with Ophn1#2 siRNA for 40 min in the absence of DHPG did
not affect the basal levels of OPHN1 (Figures 7A and 7B, control).
Thus, these data indicate that acute delivery of Ophn1#2 siRNA
can be used to prevent/block new OPHN1 synthesis induced by
DHPG.
Using the Ophn1#2 and mismatch siRNAs, we then investi-
gated the effects of blocking rapid OPHN1 synthesis on
mGluR-induced decreases in surface AMPARs. Thirty minutes
after delivery of the siRNAs, neurons were treated with DHPG
or control vehicle (for 10 min), and labeled as described above
with an N-terminal directed anti-GluR1 antibody 1 hr posttreat-
ment. Ophn1#2 siRNA did not affect basal levels of surface
GluR1, however, it hampered the decrease of surface GluR1
observed 1 hr after DHPG treatment (Figures 7C and 7D).
These data indicate that rapid OPHN1 synthesis is important
for the mGluR-induced persistent decreases in surface AMPAR
expression.
Next, we tested the effect of blocking rapid OPHN1 synthesis
on basal synaptic transmission and DHPG-inducedmGluR-LTD.
We introduced Ophn1#2 siRNA, or mismatch siRNA, into CA1
neurons of acute hippocampal slices via whole-cell recording
pipettes, and recorded evoked ESPCs. Similar to the mismatch
siRNA, Ophn1#2 siRNA did not affect basal synaptic transmis-
sion (Figure 7E). To induce LTD, we subjected the slices to
DHPG bath application (100 mM, 5 min) 30 min after breaking
into the cells. LTD was observed in cells infused with control
mismatch siRNA (Figures 7F–7H). In contrast, DHPG failed to
induce LTD in neurons infused with Ophn1#2 siRNA. Note, all
LTD experiments were performed within the same slice using
two simultaneous patch-clamp recordings of neighboring CA1
cells; each pipette was filled with one of the siRNAs. Together,
these data indicate that rapid synthesis of OPHN1 is necessary
for mGluR-LTD.
Noteworthy, previous studies demonstrated that mGluR-LTD
persists in the absence of protein synthesis in Fmr1 KO mice
(Hou et al., 2006; Nosyreva and Huber, 2006). Our data indicate
that mGluR-induced OPHN1 synthesis is independent of FMRP
(Figure 1G), raising the question as to whether mGluR-LTD in
Fmr1 KO mice still requires OPHN1 synthesis. To address this,
we introduced Ophn1#2 siRNA, or mismatch siRNA, into CA1
neurons of acute hippocampal slices prepared from Fmr1 KO
and corresponding wild-type mice, and subjected the slices to
DHPG bath application 30 min after breaking into the cells.
LTD was observed in both wild-type and Fmr1 KO cells infused
with the control mismatch siRNA (Figures 8A and 8B), which
consistent with previous reports was protein synthesis depen-
dent in wild-type, but not Fmr1 KO neurons (data not shown).
Interestingly, whereas DHPG-induced LTD was inhibited in
wild-type neurons infused with Ophn1#2 siRNA, LTD was not
affected in Fmr1 KO neurons infused with the Ophn1#2 siRNA(G) Representative traces of AMPAR-EPSCs at 60 mV of neurons recorded wi
30–35 min after LTD induction. Scale bar represents 20 ms, 20 pA.
(H) Summary graph of AMPAR-EPSCs at 60 mV of neurons recorded with pipet
LTD induction. n = 6 pairs for all conditions, **p < 0.01, paired t test; see Supple(Figures 8A and 8B). These data indicate that OPHN1 synthesis
is required for mGluR-LTD in wild-type, but not Fmr1 KO mice.
Likely, the elevated/aberrant protein synthesis caused by loss
of FMRP can compensate for the requirement of new synthesis
of OPHN1.
DISCUSSION
A common feature for mGluR-LTD in many brain regions is
the reliance on rapid and local protein synthesis (Lu¨sher and
Huber, 2010; Waung and Huber, 2009). The identities of the
newly synthesized proteins that mediate LTD, however, remain
largely elusive, with Arc/Arg3.1 being the leading candidate
‘LTD protein’ in the hippocampal CA1 area (Park et al., 2008;
Waung and Huber, 2009; Waung et al., 2008). Our study iden-
tifies the X-linked mental retardation protein, OPHN1, as a new
molecule that is rapidly synthesized upon activity and is required
for mGluR-LTD in the hippocampus. Importantly, the role of
OPHN1 inmediatingmGluR-LTD can bemolecularly dissociated
from its role in basal AMPAR-mediated synaptic transmission
(Nadif Kasri et al., 2009). Whereas the former requires OPHN1’s
interaction with Endo2/3, the latter requires OPHN1’s Rho-GAP
activity and interaction with the Homer 1b/c proteins (Figure 8C).
Group I mGluR Activation Triggers Rapid and Dendritic
OPHN1 Synthesis in an mGluR1 Dependent and FMRP
Independent Manner
Our results provide several lines of evidence for rapid dendritic
synthesis of OPHN1 in response to group I mGluR stimulation
in the hippocampal CA1 area. First, activation of group I
mGluRs triggers a fast upregulation (within 10 min) of OPHN1
in hippocampal CA1 neurons, in a process that relies on protein
synthesis from preexisting mRNA. Second, the rapid upregula-
tion of OPHN1 not only occurs in dendrites of intact hippocampal
CA1 neurons, but also in isolated dendrites that have been
severed from their cell bodies, implying that the increased
OPHN1 levels in dendrites are not caused by soma-mediated
synthesis and transport into the dendrites. Finally, rapid protein
synthesis dependent upregulation of OPHN1 is also evident in
synaptoneurosomes upon group I mGluR activation. Notably,
stimuli that elicit NMDAR-dependent LTD or -LTP, or sponta-
neous synaptic activity, do not trigger an increase in OPHN1
protein expression (this study and Nadif Kasri et al., 2009), sug-
gesting that OPHN1 induction is rather specific for mGluR-
inducing stimuli.
Our results further reveal that the mechanism by which mGluR
activity triggers rapid OPHN1 synthesis involves the activation of
mGluR1, rather than mGluR5. This is of particular interest, as
little is known about how mGluR1 is molecularly linked to the
translational machinery, and, most importantly, what its relevant
targets are in the hippocampal CA1 area (Waung and Huber,
2009). To our knowledge, OPHN1 is the first protein shown to
be rapidly induced by mGluR activity in an mGluR1 dependentth pipettes containing 25 nM mismatch siRNA or Ophn1#2 siRNA before and
tes containing mismatch siRNA or Ophn1#2 siRNA before and 30–35 min after
mental Information for quantifications.
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Figure 8. OPHN1 Synthesis Is Not Required for mGluR-LTD in Fmr1 KOMice and Model for Dual Function of OPHN1 in Basal Synaptic Func-
tion and mGluR-LTD
(A and B) DHPG-induced mGluR-LTD was measured in acute hippocampal brain slices of wild-type and Fmr1 KO mice in the presence of mismatch siRNA or
Ophn1#2 siRNA (25 nM). Top panels: representative traces of AMPAR-EPSCs at 60 mV of neurons recorded with pipettes containing mismatch siRNA or
Ophn1#2 siRNA (1) before and (2) 30–35 min after LTD induction. Scale bars represent 40 ms, 20 pA. Bottom panel: AMPAR currents 30–35 min after DHPG
application normalized to baseline AMPAR currents before DHPG application. n = 6 pairs for all conditions. (A) p < 0.01, (B) p > 0.05, paired t test; see
Supplemental Information for quantifications. In all cases neurons were infused with respective siRNA 30 min prior to DHPG application.
(C) Model for effects of OPHN1 on basal synaptic function and mGluR-LTD. Left panel: OPHN1 in basal synaptic function. Synaptic activity through NMDAR
activation drives OPHN1 into dendritic spines, where it forms a complex with Homer 1b/c proteins and through its Rho-GAP activity locally suppresses RhoA
activity and remodels actin filaments. Via its actions on Homer 1b/c and RhoA, OPHN1 regulates activity-dependent AMPAR synaptic stabilization, as well as
maintenance of spine structure, thereby permitting the maturation and strengthening of CA1 excitatory synapses (Nadif Kasri et al., 2009). Right panel: OPHN1 in
mGluR-LTD. Activation of mGluR1 triggers a rapid increase in dendritic OPHN1 synthesis. mGluR1-induced OPHN1 then engages in a complex with endophilin
A2/3 and dynamin to enhance AMPAR internalization, thereby mediating persistent decreases in surface AMPARs and LTD.
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Rapid OPHN1 Synthesis Mediates mGluR-LTDmanner. In the case of, for instance, STEP, its induction occurs in
an mGluR5 dependent manner (Zhang et al., 2008). Intriguingly,
our results also indicate that the synthesis of OPHN1 associated
with mGluR activation is FMRP independent. In contrast to Arc
and MAP1B (Hou et al., 2006; Park et al., 2008), the basal level
of OPHN1 is not elevated in the hippocampus of Fmr1 KO
mice and it can be increased upon mGluR stimulation. Hence,
OPHN1 is not likely a target for FMRP-mediated repression.
With regard to this finding, and in light of our finding that
OPHN1 synthesis is dependent on mGluR1 activation, it is note-
worthy that the function of FMRP in mGluR-stimulated protein
synthesis has been linked mainly to mGluR5 (Bassell and
Warren, 2008; Do¨len et al., 2007; Osterweil et al., 2010). For
instance, the excessive protein synthesis observed in Fmr1
KO hippocampus can be corrected by genetic reduction or312 Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc.acute pharmacological inhibition of mGluR5 (Do¨len et al., 2007;
Osterweil et al., 2010). Together, our data unveil a potential
FMRP-independent pathway linking mGluR1 to the regulation
of OPHN1 synthesis.
mGluR-Induced OPHN1 Mediates Persistent
Downregulation of Surface AMPARs and LTD Via
Interaction with Endo2/3
To determine whether OPHN1 synthesis is required for mGluR-
LTD, we used siRNAs to specifically prevent/block the mGluR-
induced rapid increase in OPHN1 levels. Our data show that
acute blockade of OPHN1 induction impedes mGluR-LTD,
indicating that OPHN1 synthesis is necessary for mGluR-LTD.
Consistent with previous reports that mGluR-LTD is mediated
by a persistent reduction in surface AMPARs (Moult et al.,
Neuron
Rapid OPHN1 Synthesis Mediates mGluR-LTD2006; Snyder et al., 2001; Waung et al., 2008), we find that acute
blockade of OPHN1 synthesis blocks the downregulation of
surface AMPARs one hour after mGluR activation. Together,
these data imply that mGluR-induced OPHN1 mediates LTD
by promoting the internalization of AMPARs.
Further support for these results, and mechanistic insight
into how OPHN1 induction could regulate AMPAR endo-
cytosis during mGluR-LTD, were provided by our finding that
OPHN1 interacts with N-BAR domain-containing Endo2/3
core components of the postsynaptic clathrin-dependent endo-
cytic machinery (Chowdhury et al., 2006). Interestingly, our data
show that mGluR stimulation enhances OPHN1 association with
Endo2/3 in a protein synthesis dependent manner. And impor-
tantly, disruption of the OPHN1-Endo2/3 interaction impedes
both mGluR-elicited persistent decreases in surface AMPARs
and LTD. Notably, these effects are not attributable to some
general disruption of AMPARs or the machinery that controls
their trafficking, because disruption of the OPHN1-Endo2/3
interaction does not affect basal AMPAR levels or basal synaptic
function. Thus, these data imply that the downregulation of
surface AMPARs during mGluR-LTD requires OPHN1 induction
and its ability to bind Endo2/3. Likely, OPHN1 induced upon
mGluR activation, via the regulation of Endo2/30s activities,
increases the rate of AMPAR endocytosis.
While our data demonstrate a requirement for OPHN1
synthesis in mGluR-LTD, previous studies have shown that
newly synthesized Arc protein is also required for this process
(Waung et al., 2008), implying that both mGluR-induced
OPHN1 and Arc, and perhaps other proteins, such as MAP1B
and STEP (Davidkova and Carroll, 2007; Zhang et al., 2008),
are likely to contribute jointly to LTD, and, moreover, that
mGluR1/5 must coordinate the various translational control
mechanisms involved. Of particular interest is that Arc also inter-
acts with Endo2/3 and this interaction is important for the role of
Arc in AMPAR trafficking (Chowdhury et al., 2006). Of note,
OPHN1 and Arc interact with different regions of Endo2/3, with
OPHN1 binding to the SH3 domain of Endo2/3, and Arc to the
C terminus of the N-BAR domain of Endo2/3 (Chowdhury
et al., 2006). Therefore, it is possible that newly synthesized
OPHN1 and Arc cooperate at the level of Endo2/3 to promote
mGluR-driven AMPAR endocytosis, either by regulating distinct
aspects of Endo2/3 function or by promoting/engaging a
common mechanism, at least under wild-type conditions.
Importantly, a different mode of mGluR-LTD regulation seems
to occur upon loss of FMRP. Indeed, previous studies demon-
strated that mGluR-LTD in Fmr1 KO mice is distinctly different
from that in wild-type mice. For instance, whereas mGluR-LTD
in wild-type mice is protein synthesis dependent, it persists in
the absence of protein synthesis in Fmr1 KO mice (Hou et al.,
2006; Nosyreva and Huber, 2006). Consistent with this, our
data show that acute blockade of OPHN1 synthesis does not
affect mGluR-LTD in Fmr1 KO mice, albeit it clearly blocks
mGluR-LTD in wild-type mice, indicating that OPHN1 synthesis
is required for mGluR-LTD under wild-type conditions but not
upon loss of FMRP. We conjecture that the elevated/aberrant
protein synthesis caused by loss of FMRP can compensate for
the requirement of new synthesis of OPHN1 and likely other
proteins as well.OPHN1 Serves Multiple Functions at the Hippocampal
CA1 Synapse
In a previous study, we demonstrated that postsynaptic OPHN1
controls the maturation and strengthening of CA1 excitatory
synapses in response to synaptic activity and NMDAR activation
(Nadif Kasri et al., 2009). Combined with our current work,
this indicates that OPHN1 carries out multiple functions at the
hippocampal CA1 synapse. Our data show that the effects of
OPHN1 on mGluR-LTD and basal synaptic strength are disso-
ciable and involve distinct protein-protein interactions. As
discussed above, disruption of the OPHN1-Endo2/3 interaction
blocks mGluR-induced LTD and the associated long-term
decreases in surface AMPARs. Yet, disruption of the OPHN1-
Endo2/3 interaction does not interfere with basal synaptic func-
tion, or NMDAR-dependent LTP (data not shown), indicating that
OPHN1 regulation of mGluR-LTD via its interaction with Endo2/3
is independent of its role in potentiating synaptic strength. We
posit that OPHN1, upon induction by mGluR activity, engages
in a complex with Endo2/3 to enhance AMPAR internalization,
thereby mediating persistent decreases in surface AMPARs
and LTD.
On the other hand, we find that OPHN1’s interaction with
Homer 1b/c is not required for its role in mGluR-LTD, but that
this interaction, as well as the Rho-GAP activity of OPHN1, is
important for its role in regulating basal synaptic function. The
GAP activity of OPHN1 toward RhoA is also required for its role
in controlling structural and functional changes during LTP
(Nadif Kasri et al., 2009). As to how OPHN1 could mediate the
strengthening of synapses via interactions with Homer 1b/c and
RhoA, we previously demonstrated that stabilizing AMPARs at
the synapse prevents the defects in synaptic structure and func-
tion caused by extended OPHN1 knockdown (Nadif Kasri et al.,
2009). Hence, a conceivable scenario is that OPHN1 via its
interactionswithHomer 1b/candRhoA regulates the stabilization
of AMPARs at the synapse, thereby controlling activity depen-
dent maturation and strengthening of synapses (Figure 8C).
Together, these findings point to a multifunctional role for
OPHN1 at CA1 synapses. Independent of its role in activity
driven glutamatergic synapse development, regulated OPHN1
synthesis plays a critical role in mGluR-dependent LTD. Thus,
it is conceivable that on one hand OPHN1 might play an impor-
tant role in synapse maturation and circuit wiring during early
development, on the other hand the regulated OPHN1 synthesis
could operate during adulthood toweaken synapses in response
to behaviorally relevant stimuli. In light of the previously reported
role for LTD in behavioral flexibility and novelty detection (Kemp
and Manahan-Vaughan, 2007; Lu¨scher and Huber, 2010), and
the association of OPHN1 loss of function with altered social
behavior and novelty-driven hyperactivity (des Portes et al.,
2004; Khelfaoui et al., 2007; Zanni et al., 2005), the requirement
for OPHN1 in mGluR-LTD could offer an intriguing potential
explanation for some of the behavioral deficits exhibited by
OPHN1 patients.EXPERIMENTAL PROCEDURES
DNA constructs, virus production, siRNAs, peptides, and fluorescence in situ
hybridization assay are included in Supplemental Experimental Procedures.Neuron 72, 300–315, October 20, 2011 ª2011 Elsevier Inc. 313
Neuron
Rapid OPHN1 Synthesis Mediates mGluR-LTDAcute Brain Slices and Hippocampal Slice and Dissociated Cultures
Acute slices were prepared from 21–30-day-old rats (Sprague-Dawley), or
3.5–6-week-old Fmr1 KO mice (FVB.129P2-Fmr1tm1Cgr/J) and corresponding
littermates. Briefly, animals were anesthetized with isoflurane and decapi-
tated; the brains were quickly removed and chilled in ice-cold dissection
buffer. Coronal slices (400 mm) were cut in dissection buffer using a VT-
1000S vibratome (Leica) and transferred to a storage chamber containing arti-
ficial cerebrospinal fluid (ACSF) for 30 min at 32C. Slices were then incubated
at RT for 1–3.5 hr prior to use in experiments. See Supplemental Experimental
Procedures for details on buffers, and for the preparation, infection, and trans-
fection of hippocampal slice and dissociated cultures.
Biochemical Analysis, AMPA Receptor Surface Labeling,
and Immunofluorescence
Western blotting, pull-down assays, coimmunoprecipitations, synaptoneuro-
some preparation, AMPAR surface labeling, and immunofluorescence were
performed largely as described (Govek et al., 2004; Nadif Kasri et al., 2009;
Park et al., 2008; Waung et al., 2008). See Supplemental Experimental Proce-
dures for details.
Cut Dendrite Experiments
Dendrites in CA1 region of hippocampal slices were cut at the border of the
stratum pyramidale and stratum radiatum with a microdissection knife under
a dissection microscope (Huber et al., 2000). Ten minutes after treatment
with DHPG or control vehicle (ACSF), slices were fixed, embedded in agarose
(3%), resectioned at 40 mm, and processed for immunofluorescence staining
with anti-OPHN1 and anti-bIII-tubulin antibodies.
Electrophysiology
Cultured and acute brain slice whole-cell recordings were obtained with Multi-
clamp 700B amplifiers (Axon Instruments). For the former, cultured slices from
P7–P9 rats (Sprague-Dawley) were infected with indicated lentiviruses at DIV1,
and 8–10 days later, whole-cell recordings were obtained simultaneously from
an infected and an adjacent uninfected neuron in the CA1 region under visual
guidance using epifluorescence and transmitted light illumination. For the
latter, acute hippocampal slices were prepared from 21–30-day-old rats or
23–28-day-old mice and placed in a recording chamber perfused with artificial
cerebrospinal fluid (ACSF) solution. See Supplemental Experimental Proce-
dures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, Supplemental Quantifica-
tions, and Supplemental Experimental Procedures and can be found with
this article online at doi:10.1016/j.neuron.2011.09.001.
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